Stabenow, Cummings Call for GAO Review of Potential Patent Infringement by Gilead Pharmaceuticals
June 18, 2019
June 18, 2019
WASHINGTON, June 18 -- Sen. Debbie Stabenow, D-Michigan, issued the following news release:
* * *
- Gilead's HIV-prevention drug, Truvada, relies on taxpayer-funded research and government patents but is unaffordable for most Americans
* * *
U.S. Senator Debbie Stabenow (D-MI), Ranking Member of the Health Subcommittee of the Senate Finance Committee, and U.S. Congressman Elijah Cummings (D-MD), Chairman of the House Oversight and Reform C . . .
* * *
- Gilead's HIV-prevention drug, Truvada, relies on taxpayer-funded research and government patents but is unaffordable for most Americans
* * *
U.S. Senator Debbie Stabenow (D-MI), Ranking Member of the Health Subcommittee of the Senate Finance Committee, and U.S. Congressman Elijah Cummings (D-MD), Chairman of the House Oversight and Reform C . . .